In an interview with ETHealthworld, Eddy Pasquier, Founder, Metronomics Global Health Initiative, France, talks about the research and drug developments taking place for finding better cures in childhood cancer.
More specifically, he talk about drug repositioning and his work on propranolol for angiosarcoma.